文献速递肝胆胰外科

局部晚期与(交界)可切除胰腺癌患者切除术后短期和长期结局评估

Evaluation of Short and Long-term Outcomes After Resection in Patients With Locally Advanced Versus (Borderline) Resectable Pancreatic Cancer.
PubMed 文献 · Ann Surg · 2024-04-01

该研究利用两个前瞻性全国数据库,纳入879例患者,比较局部晚期胰腺癌(LAPC)诱导化疗后切除与(交界)可切除胰腺癌((B)RPC)直接切除的结局。LAPC组C级胃排空延迟更常见(9% vs 3%,P=0.03),其余胰腺特异性并发症、90天死亡率、R0切除率、无病间期和总生存均相当。

要点

  • LAPC组C级胃排空延迟发生率高于(B)RPC组(9% vs 3%,P=0.03)。
  • 两组90天死亡率、R0切除率、无病间期和总生存均无显著差异。
  • 经仔细选择的LAPC患者行胰腺切除术后并发症和死亡率可接受。

核心结论

  • 在仔细选择的LAPC患者中,胰腺切除术后胰腺特异性并发症、死亡率和生存与(B)RPC切除患者相当。

研究设计与样本

  • 利用两个前瞻性全国数据库,纳入接受 upfront 肿瘤切除的(B)RPC患者和诱导治疗后切除的LAPC患者,共879例,其中LAPC 103例(12%),(B)RPC 776例(88%)。

主要发现

  • LAPC组世界卫生组织体能评分和年龄校正Charlson合并症指数较低。
  • 术后胰腺特异性并发症两组相当,但C级胃排空延迟在LAPC组更常见(9% vs 3%,P=0.03)。
  • 90天死亡率两组相当。
  • R0切除率两组分别为LAPC 54% vs (B)RPC 48%(P=0.21)。
  • 无病间期两组均为13个月(P=0.12);自诊断日起总生存LAPC组24个月 vs (B)RPC组19个月(P=0.34)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate short and long-term outcomes after pancreatectomy in patients with locally advanced pancreatic cancer (LAPC) compared with patients with (borderline) resectable pancreatic cancer [(B)RPC]. BACKGROUND: Selected patients diagnosed with LAPC are increasingly undergoing resection after induction chemotherapy. To evaluate the benefit of this treatment approach, it is helpful to compare outcomes in resected patients with primary LAPC to outcomes in resected patients with primary (B)RPC. METHODS: Two prospectively maintained nationwide databases were used for this study. Patients with (B)RPC undergoing upfront tumor resection and patients with resected LAPC after induction therapy were included. Outcomes were postoperative pancreas-specific complications, 90-day mortality, pathologic outcomes, disease-free interval, and overall survival. RESULTS: Overall, 879 patients were included; 103 with LAPC (12%) and 776 with (B)RPC (88%). Patients with LAPC had a lower World Health Organization performance score and ageadjusted Charlson Comorbidity Index. Postoperative pancreas-specific complications were comparable between groups, except delayed gastric emptying grade C, which occurred more often in patients with LAPC (9% vs 3%, P = 0.03). Ninety-day mortality was comparable. About half of the patients in both groups [54% in LAPC vs 48% in (B)RPC, P = 0.21] had a radical resection (R0). Disease-free interval was 13 months in both groups ( P = 0.12) and overall survival from the date of diagnosis was 24 months in patients with LAPC and 19 months in patients with (B)RPC ( P = 0.34). CONCLUSIONS: In our nationwide prospective databases, pancreas-specific complications, mortality, and survival in patients with LAPC after pancreatectomy are comparable with those undergoing resection for (B)RPC. These outcomes suggest that postoperative morbidity and mortality after tumor resection in carefully selected patients with LAPC are acceptable.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Brada LJH, Schouten TJ, Daamen LA, et al. Evaluation of Short and Long-term Outcomes After Resection in Patients With Locally Advanced Versus (Borderline) Resectable Pancreatic Cancer. Ann Surg. 2024. PMID: 38557955. doi:10.1097/SLA.0000000000006289

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。